Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy

Journal of the Neurological Sciences

Volumn 287, Issue 1-2, 2009, Pages 178-184

  Koike, Haruki ^a   Ando, Yukio ^b   Ueda, Mitsuharu ^b   Kawagashira, Yuichi ^a   Iijima, Masahiro ^a   Fujitake, Junko ^c   Hayashi, Michiyuki ^c   Yamamoto, Masahiko ^d   Mukai, Eiichiro ^e   Nakamura, Tomohiko ^a   Katsuno, Masahisa ^a   Hattori, Naoki ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c KYOTO CITY HOSPITAL   (Japan)

^d AICHI GAKUIN UNIVERSITY   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

Amyloid; Autopsy; Congo red staining; Familial amyloid polyneuropathy; Surface enhanced desorption ionization time of flight mass spectrometry; Transthyretin

Indexed keywords

AMYLOID PROTEIN; CONGO RED; METHIONINE; PREALBUMIN; VALINE;

ARTICLE; AUTOPSY; BIREFRINGENCE; CONTROLLED STUDY; FAMILIAL AMYLOID POLYNEUROPATHY; HAND; HEART; HUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TIME OF FLIGHT MASS SPECTROMETRY;

ADRENAL GLANDS; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; COLORING AGENTS; CONGO RED; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC MARKERS; GENETIC TESTING; HUMANS; KIDNEY; MALE; METHIONINE; MIDDLE AGED; MYOCARDIUM; PERIPHERAL NERVES; PREALBUMIN; STAINING AND LABELING; VALINE; VISCERA; YOUNG ADULT;

EID: 70350622959     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.07.028     Document Type: Article

References (39)

1. Benson M.D., and Cohen A.S. Generalized amyloid in a family of Swedish origin. A study of 426 family members in seven generations of a new kindship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med 86 (1977) 419-424
2. Ikeda S., Hanyu N., Hongo M., Yoshioka J., Oguchi H., Yanagisawa N., et al. Hereditary generalized amyloidosis with polyneuropathy: clinicopathological study of 65 Japanese patients. Brain 110 (1987) 315-337
3. Nakazato M., Shiomi K., Miyazato M., and Matsukura S. Type 1 familial amyloidotic polyneuropathy in Japan. Intern Med 31 (1992) 1335-1338
4. Holmgren G., Costa P.M., Andersson C., Asplund K., Steen L., Beckman L., et al. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 31 (1994) 351-354
5. Reilly M.M., Adams D., Booth D.R., Davis M.B., Said G., Laubriat-Bianchin M., et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 118 (1995) 849-856
6. Sousa A., Coelho T., Barros J., and Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 60 (1995) 515-521
7. Ikeda S., Nakazato M., Ando Y., and Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 58 (2002) 1001-1007
8. Ando Y., Nakamura M., and Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62 (2005) 1057-1062
9. Plante-Bordeneuve V., Ferreira A., Lalu T., Zaros C., Lacroix C., Adams D., et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 69 (2007) 693-698
10. Misu K., Hattori N., Nagamatsu M., Ikeda S., Ando Y., Nakazato M., et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan; clinicopathological and genetic features. Brain 122 (1999) 1951-1962
11. Koike H., Misu K., Ikeda S., Ando Y., Nakazato M., Ando E., et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- versus late-onset form. Arch Neurol 59 (2002) 1771-1776
12. Ikeda S. Is familial amyloid polyneuropathy rare? DNA testing is changing the concept of this disease. Neurology 69 (2007) 627-628
13. Koike H., Misu K., Sugiura M., Iijima M., Mori K., Yamamoto M., et al. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 63 (2004) 129-138
14. Koike H., Kawagashira Y., Iijima M., Yamamoto M., Hattori N., Tanaka F., et al. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. J Neurol 255 (2008) 1526-1533
15. Ando Y., and Suhr O.B. Autonomic dysfunction in familial amyloid polyneuropathy (FAP). Amyloid: Int J Exp Clin Invest 5 (1998) 288-300
16. Misu K., Hattori N., Ando Y., Ikeda S., and Sobue G. Anticipation in early- but not late-onset familial amyloid polyenuropathy (TTR Met 30) in Japan. Neurology 55 (2000) 451-452
17. Sobue G., Koike H., Misu K., Hattori N., Yamamoto M., Ikeda S., et al. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan. Amyloid: J Protein Folding Disord 10 Suppl 1 (2003) 32-38
18. Coelho T., Sousa A., Lourenco E., and Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 31 (1994) 293-299
19. Conceição I., and De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 35 (2007) 116-118
20. Fujitake J., Mizuta H., Fujii H., Ishikawa Y., Katsuyama E., Takasu K., et al. Late-onset familial amyloid polyneuropathy: an autopsy study of two Japanese brothers. Amyloid: J Protein Folding Disord 10 (2003) 198-205
21. Sobue G., Hashizume Y., Mukai E., Hirayama M., Mitsuma T., and Takahashi A. X-linked recessive bulbospinal neuronopathy, a clinicopathological study. Brain 112 (1989) 209-232
22. Sobue G., Nakao N., Murakami K., Yasuda T., Sahashi K., Mitsuma T., et al. Type I familial amyloid polyneuropathy. A pathological study of the peripheral nervous system. Brain 113 (1990) 903-919
23. Kaplan B., Hrncic R., Murphy C.L., Gallo G., Weiss D.T., and Solomon A. Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts of tissue. Methods Enzymol 309 (1999) 67-81
24. Gustavsson A., Jahr H., Tobiassen R., Jacobson D.R., Sletten K., and Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 73 (1995) 703-708
25. Kyle R.A., Spittell P.C., Gertz M.A., Li C.Y., Edwards W.D., Olson L.J., et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 101 (1996) 395-400
26. Ng B., Connors L.H., Davidoff R., Skinner M., and Falk R.H. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 165 (2005) 1425-1429
27. Cornwell III G.G., Murdoch W.L., Kyle R.A., Westermark P., and Pitkänen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 75 (1983) 618-623
28. Tashima T., Kitamoto T., Tateishi J., Ogomori K., and Nakagaki H. Incidence and characterization of age related amyloid deposits in the human anterior pituitary gland. Virchows Arch 412 (1988) 323-327
29. Röcken C., Eick B., and Saeger W. Senile amyloidosis of the pituitary and adrenal glands. Virchows Arch 429 (1996) 293-299
30. Westermark P., Eriksson L., Engström U., Eneström S., and Sletten K. Prolactin-derived amyloid in the aging pituitary gland. Am J Pathol 150 (1997) 67-73
31. Bergström J., Gustavsson A., Hellman U., Sletten K., Murphy C.L., Weiss D.T., et al. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 206 (2005) 224-232
32. Ihse E., Ybo A., Suhr O., Lindqvist P., Backman C., and Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 216 (2008) 253-261
33. Kato-Motozaki Y., Ono K., Shima K., Morinaga A., Machiya T., Nozaki I., et al. Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus. J Neurol Sci 270 (2008) 133-140
34. Magnus J.H., and Stenstad T. Proteoglycans and the extracellular matrix in amyloidosis. Amyloid: Int J Exp Clin Invest 4 (1997) 121-134
35. Sousa M.M., do Amaral J.B., Guimarães A., and Saraiva M.J. Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy. FASEB J 19 (2005) 124-126
36. Carrino D.A., Onnerfjord P., Sandy J.D., Cs-Szabo G., Scott P.G., Sorrell J.M., et al. Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin. J Biol Chem 278 (2003) 17566-17572
37. Sekijima Y., Wiseman R.L., Matteson J., Hammarström P., Miller S.R., Sawkar A.R., et al. The biological and chemical basis for tissue-selective amyloid disease. Cell 121 (2005) 73-85
38. Terazaki H., Ando Y., Fernandes R., Yamamura K., Maeda S., and Saraiva M.J. Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant. Lab Invest 86 (2006) 23-31
39. Sekijima Y., Kelly J.W., and Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des 14 (2008) 3219-3230